Movement Alert|Aehr Test Rises 8.51% in Regular Trading, Rebounding With Sector Strength Amid Continued AI Testing Optimism

Market Focus
Sep 29

On September 29, Aehr Test rose 8.51% in regular trading, trading at $107.12 per share, with turnover of $51.53 million. The stock rebounded sharply from the prior session's 8.48% decline, supported by broad strength across the semiconductor equipment sector.

On the news front, multiple investment banks have recently expressed bullish views on the company's AI-driven growth trajectory. Oppenheimer initiated coverage with an Outperform rating and a $120 price target, citing that rising AI chip power and package value significantly increases the cost of late failures, positioning the company for an AI-driven inflection point. Jefferies also initiated coverage with a Buy rating and a $175 target. The company has recently secured a $22 million follow-on order from its lead wafer-level AI processor customer and a follow-on order from its silicon photonics customer, while its Sonoma platform received a record $41 million order. AI data center business now accounts for approximately 70% of revenue, completing a structural transformation away from silicon carbide.

Within the Semiconductor Equipment sector, the overall sector performed strongly. Among individual stocks, Applied Materials up 3.66%, ASML Holding NV up 2.17%, Lam Research up 2.88%, KLA Corporation up 3.34%, AXT Inc up 9.53%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10